Chronic Myelogenous Leukemia Clinical Practice Guidelines in Oncology

Chronic myelogenous leukemia (CML) accounts for 15% of adult leukemias. In 2005, an estimated 4,600 cases will be diagnosed, and 850 patients will die of the disease. The median age of disease onset is 53 years; however, CML occurs in all age groups, with an increasing proportion of younger patients in more recent series. ML progresses from a chronic phase to a rapidly fatal blastic phase, generally over 3 to 5 years. The blast phase is often preceded by a transition period, called the accelerated phase, which is marked by the acquisition of new cytogenetic abnormalities in 50% to 80% of patients. Several definitions of the accelerated phase of the disease are summarized.

For the most recent version of the guidelines, please visit

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 265 75 6
PDF Downloads 160 29 4
EPUB Downloads 0 0 0